Mesenchymal Stem Cells Differentiation in Health and Disease
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 20 January 2025 | Viewed by 8138
Special Issue Editor
Interests: mesenchymal stem cells; adipogenic differentiation; osteoblastic differentiation; chondrogenic differentiation; haematopoietic stem cells; cell metabolism
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Mesenchyme is a loosely organized embryonic connective tissue of undifferentiated cells, predominantly originating from the embryonic mesoderm, although it may also be derived from the neural crest, an ectodermal cell population, via an epithelial-to-mesenchymal transition (EMT). Mesenchyme is composed morphologically through a prominent extracellular matrix containing a loose aggregate of reticular fibrils and unspecialized mesenchymal stem cells. Unlike epithelial cells, organized into closely adherent sheets, mesenchymal cells can migrate easily, sustaining a connective tissue production during embryogenesis. In recent decades, a role has been recognized for the migration ability of mesenchymal stem cells in tumor-targeted delivery vehicles and tumor-related stroma formation. Mesenchymal stem cells (MSCs) are multipotent stromal cells able to self-renew and differentiate into many different types of cells, including bone, cartilage, muscle, fat cells and connective tissue. They can be isolated from a variety of tissues, such as bone marrow, adipose tissue, the placenta, cord blood and polyps. MSCs are characterized by the expression of CD73, CD90 and CD105 cell markers and are negative for hematopoietic and endothelial markers (CD14, CD11b, CD19, CD79, CD34, CD45 and HLA-DR). make These cells have been found to be a good source for experimental practice due to their ease of harvest and quantity obtained; indeed, they emerged in the past two decades as promising candidates for clinical applications, especially in cell replacement therapies for mesenchymal tissues such as bone and cartilage. The dysregulation of the MSC differentiation process occurs frequently in many bone diseases, for example, osteogenesis imperfecta or sarcoma. Investigating the molecular basis involved in regulating the differentiation and maturation of MSCs into osteoblastic cells or chondrocytes in health and disease conditions is essential for the development of innovative approaches for therapy. This Special Issue of IJMS provides an opportunity for the description of recent original research advancements in the field of MSCs, focusing on transcriptional factors involved in osteoblastic differentiation. We are particularly interested in the analysis of a range of transcription factors with regulatory roles at different stages during the osteoblastic differentiation of MSCs in order to gain an understanding of bone development in health and disease.
Dr. Emanuela Chiarella
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- mesoderm
- mesenchymal stem cells
- osteogenic differentiation
- chondrogenic differentiation
- adipogenic differentiation
- MSC clinical applications
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.